Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design
Nanoparticles as cancer therapeutic carrier fail in clinical translation due to complex biological environments in vivo consisting of electrolytes and proteins which render nanoparticle aggregation and unable to reach action site. This review identifies the desirable characteristics of nanoparticles...
Published in: | Advances in Colloid and Interface Science |
---|---|
Main Author: | Lim S.H.; Wong T.W.; Tay W.X. |
Format: | Review |
Language: | English |
Published: |
Elsevier B.V.
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185277567&doi=10.1016%2fj.cis.2024.103094&partnerID=40&md5=e3fdd6a2f902ce13f8acd5d56f1740af |
Similar Items
-
Choice of nanocarrier for pulmonary delivery of cancer therapeutics
by: Wong T.W.
Published: (2020) -
“Drug-Free” chitosan nanoparticles as therapeutic for cancer treatment
by: Iskandar A.; Kim S.-K.; Wong T.W.
Published: (2024) -
Comparison of virus-capsid mimicking biologic-shell based versus polymeric-shell nanoparticles for enhanced oral insulin delivery
by: Cui Z.; Cui S.; Qin L.; An Y.; Zhang X.; Guan J.; Wong T.W.; Mao S.
Published: (2023) -
Functionalized chitosan for cancer nano drug delivery
by: Zaiki Y.; Iskandar A.; Wong T.W.
Published: (2023) -
Biodegradable drug delivery systems for cancer therapy
by: Wong T.W.; Sriamornsak P.; Dass C.R.
Published: (2017)